Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1289

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 6
Chunk 1289
---
521  
    $11.14  
     9.38 

    F-23 

    Weighted Average  
    Weighted Average 

    Number of Shares  
    Exercise Price   
    Remaining Life 

    Stock Options 

    Outstanding December 31, 2022 
     50,002  
    $22.68  
     9.76 

    Granted 
     158,670  
    $22.68  
     9.16 

    Expired 
     (11,111) 
    $22.68  
     — 

    Exercised 
     —  
    $—  
     — 

    Outstanding December 31, 2023 
     197,560  
    $22.68  
     9.08 

    Exercisable December 31, 2023 
     84,131  
    $22.68  
     8.98 

A
summary of the status of the Company’s nonvested options as of December 31, 2024, and 2023, and changes during years ended
December 31, 2024, and 2023, is presented below:

 Schedule
of nonvested options

    Non-vested Options 
    Options  
    Weighted- Average Exercise Price 

    Non-vested at December 31, 2023 
     113,429  
    $22.68 

    Granted 
     684,000  
    $1.26 

    Vested 
     (236,501) 
    $7.58 

    Forfeited 
     —  
    $— 

    Non-vested at December 31, 2024 
     560,928  
    $2.93 

    Non-vested Options 
    Options  
    Weighted- Average Exercise Price 

    Non-vested at December 31, 2022 
     45,556  
    $22.68 

    Granted 
     158,670  
    $22.68 

    Vested 
     (90,797) 
    $22.68 

    Forfeited 
     —  
    $— 

    Non-vested at